US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.4802 -0.0085 (-1.74%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
HeartBeam Reports Second Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces First Peer-Reviewed Publication Based on Its VECG Technology
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks
From HeartBeam, Inc.
Via Business Wire
News headline image
Recap: HeartBeam Q1 Earnings ↗
 
Via Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Deborah Castillo to Lead Regulatory Strategy and Execution
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q2 2023 Results Call, Webcast
Via Investor Brand Network
News headline image
HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Physician, Researcher to Board of Directors
Via Investor Brand Network
News headline image
HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Wealth of Expertise to Its Board with Appointments of Ken Nelson and Mark Strome
Via Investor Brand Network
News headline image
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
Strategic Alliance with Samsung and Collaboration with Dept. of Veterans Affairs to Advance Use of Unique 3-D Telehealth Technology for Heart Attack Detection and Quicker Response: BEAT
Via Get News
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
Via Investor Brand Network
News headline image
Monitoring Cardiac Symptoms? HeartBeam Extends Pact With Samsung For LIVMOR Solutions ↗
 
Via Benzinga
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
Via Investor Brand Network
News headline image
HeartBeam (NASDAQ: BEAT) Enters Strategic Alliance Agreement with Samsung for Cardiac Care Solutions
HeartBeam Collaborates with Samsung to Boost Cardiac Diagnostic Capabilities HeartBeam, Inc. (NASDAQ: BEAT), renowned for their pioneering 3D-vector electrocardiogram (VECG) 
Via Spotlight Growth
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
HeartBeam Enters into Strategic Alliance Agreement with Samsung
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Granted Key Patent for Use in Innovative System Designed to Help Evaluate Cardiac Symptoms
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces FDA 510(k) Submission of HeartBeam AIMIGo(TM) Solution
Via Investor Brand Network
News headline image
HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2023 Financial Report, Corporate Updates
Via Investor Brand Network
News headline image
HeartBeam Reports First Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
$25 Million Capital Raise Completed to Support Commercialization of Unique 3-D Telehealth Technology for Heart Attack Detection and Rapid Response: HeartBeam, Inc. (NASDAQ: BEAT)
Via Get News
Topics Credit Cards
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes $25M Capital Raise to Achieve Upcoming Milestones, Extend Cash Runway
Via Investor Brand Network
News headline image
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance
From HeartBeam, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >